期刊文献+

金黄地鼠颊囊癌前病变癌变的综合监测研究——DNA、SPF、AgNOR、PCNA及APO的研究 被引量:4

Combination of cell proliferation and apoptosis to predict malignant potential of Golden Hamster cheek pouch premalignancy
原文传递
导出
摘要 目的评价DNA含量(DI)、倍体、S期细胞比例(SPF)、银染核仁形成区(AgNOR)、增殖细胞核抗原(PCNA)及细胞凋亡指数(APO)在口腔粘膜癌前病变癌变监测中的价值及临床应用意义。方法应用流式细胞仪(FCM)、免疫组化等方法对DMBA致地鼠颊囊粘膜癌前病变及癌变过程中的DNA含量、倍体、SPF、AgNOR及APO进行定量检测。结果在Ⅰ—Ⅳ组间(Ⅰ组为正常颊囊粘膜、Ⅱ组为上皮单纯增生、Ⅲ组为上皮异常增生、Ⅳ组为癌肿组)DNA含量、异倍体出现率、SPF、AgNOR计数及PCNA表达依次递增;APO指数随Ⅰ—Ⅲ组依次升高,Ⅳ组时下降。多元逐步判别分析,建立判别函数方程,回代判别准确率为90%。结论本实验结果提示综合监测为口腔粘膜癌前病变癌变的细胞动力学的动态规律的观察提供有益的资料,并对进一步从分子生物学水平研究癌前病变及其癌变将具有重要价值。 Objective Combination of cell proliferation and apoptosis to predict malignant potential of DMBA-induced Goledn Hamster cheek pouch premalignancy.Methods DMBA-induced golden hamster cheek pouch carcinogenesis model was done.There were four histological types of the model inclouding normal,hyperplasia,dysplasia and carcinoma.DNA Index(DI),SPF,PCNA,AgNOR and apoptosis were detected by flow cytometry(FCM),immunohistochemical and histochemical methods.Results DI,SPF,PCNA and AgNOR indices were increased from normal to premalignancy but decreased after carcinogenesis.Then the discriminant function equation was found using these indices at 90.01 percent of backsubstitution accuracy.Conclusion The indices of DI,SPF,PCNA,AgNOR and apoptosis can reflect the cellular dynaic changes of Hamster cheek pouch carcinogenesis.They revealed the incipient celluar alterations which were not evident in routine pathological examine and contributed to the characterization of different states of carcinogenesis in this model.
出处 《临床口腔医学杂志》 1999年第2期95-98,共4页 Journal of Clinical Stomatology
关键词 癌前状态 监测 口腔粘膜癌 颊囊 SPF AGNOR precancerous conditions forecasting
  • 相关文献

参考文献2

二级参考文献2

共引文献15

同被引文献41

  • 1李方.细胞凋谢与肿瘤[J].国外医学(肿瘤学分册),1994,21(4):193-196. 被引量:4
  • 2Dowdy SC, O′ Kane DJ, Keeney GL, et al. Telomerase activity in sex cord- stromal tumors of the ovary [J]. Gynecol Oncol, 2001, 82(2): 257-260.
  • 3Poremba C, Heine B, Diallo R, et al. Telomerase as a prognostic marker in breast cancer: high - throughput tissue microarray analysis of hTERT and hTR [J]. J Pathol, 2002, 198(2): 181 - 189.
  • 4Shiratsuchi M, Muta K, Abe Y, et al. Clinical significance of telomerase activity in multiple myeloma [J]. Cancer, 2002, 94(8): 2232- 2238.
  • 5OishiT, KigawaJ, MinagawaY, etal. Alteration oftelomerase activity associated with development and extension of epithelial ovarian cancer [J]. Obstet Gynecol, 1998, 91(4): 568-571.
  • 6Shahin MS, Hughos JH, Sood AK, et al. The prognostic significance of po53 tumor suppreessor gene alterations in ovarian carcinoma [ J ].Cancer, 2000, 89(9): 2006-2017.
  • 7Eltabbakh GH, Belinson JL, Kennedy AW, et al. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer [J]. Cancer, 1997, 80(5): 892 - 898.
  • 8Kobayashi T, Sugawara Y, Shi YZ, et al. Telomerase expression and p53 status in hepatocellular carcinoma [ J ]. Am J Gastroenterol,2002, 97(12): 3166-3171.
  • 9Karlseder J, Broccoli D, Dai Y, et al. p53 - and ATM - dependent apoptosis induced by telomeres lacking TRF2 [J]. Science, 1999,283(5406): 1321 - 1325.
  • 10Vaziri H, Benchimol S. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase[J]. Oncogene, 1999, 18(53): 7676-7680.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部